Effects of Eptifibatide on the Microcirculation After Primary Angioplasty in Acute ST-Elevation Myocardial Infarction: A Trans-Thoracic Coronary Artery Doppler Study

Cardiovascular atherosclerosis is the most common disease in the industrial countries. In the United States of America more than 1 million patients every year are admitted to the coronary care unit with suspected acute myocardial infarction (Yusuf et al, 2004; American Heart Association, 2007). The incidence of acute myocardial infarction in USA is 865000, 565000 of them new infarctions annually. In Europe, the situation is similar to the USA, however in northern countries the incidence is higher than in southern countries (Lopez et al, 2006). In the emerging market economies in Eastern Europe, higher cardiovascular mortality is found. The burden of cardiovascular and coronary heart disease in developing countries is approaching that in developed countries. Thus the problem is a worldwide problem and international joint efforts are needed in order to treat this still prevalent disease.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.5772/28942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute myocardial infarction.

  2014cited by this paper
• Echocardiography - In Specific Diseases

  2012cited by this paper
• Atherosclerotic Cardiovascular Disease

  2011cited by this paper
• Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

  2011influential reference
• Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.

  2010cited by this paper
• Comparison by meta-analysis of eptifibatide and tirofiban to abciximab in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

  2010influential reference
• Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

  2010cited by this paper
• Detection of severe left anterior descending coronary artery stenosis by transthoracic evaluation of resting coronary flow velocity dynamics

  2010cited by this paper
• Analysis of serial coronary artery flow patterns early after primary angioplasty: new insights into the dynamics of the microcirculation.

  2008cited by this paper
• Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2007cited by this paper
• Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates

  2006cited by this paper
• Tackling the challenge of cardiovascular disease burden in developing countries.

  2004cited by this paper
• Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

  2004cited by this paper
• Acute myocardial infarction

  2003cited by this paper
• Coronary Flow Velocity Pattern Immediately After Percutaneous Coronary Intervention as a Predictor of Complications and In-Hospital Survival After Acute Myocardial Infarction

  2002cited by this paper
• Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction.

  2002cited by this paper
• Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction: A TIMI 14 Substudy

  2001cited by this paper
• Simple detection of severe coronary stenosis using transthoracic Doppler echocardiography at rest.

  2001cited by this paper
• Assessment of coronary flow velocity with transthoracic Doppler echocardiography during dobutamine stress echocardiography.

  2001cited by this paper
• ST segment resolution as a tool for assessing the efficacy of reperfusion therapy.

  2001cited by this paper
• Assessment of flow velocity reserve by transthoracic Doppler echocardiography and venous adenosine infusion before and after left anterior descending coronary artery stenting.

  2001cited by this paper
• Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.

  2000cited by this paper
• Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study.

  2000cited by this paper
• Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.

  2000influential reference
• Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

  2000cited by this paper
• Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation.

  2000cited by this paper
• Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.

  2000cited by this paper
• Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome.

  1999cited by this paper
• Can Coronary Blood Flow Velocity Pattern After Primary Percutaneous Transluminal Coronary Angiography Predict Recovery of Regional Left Ventricular Function in Patients With Acute Myocardial Infarction

  1999cited by this paper
• New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler.

  1999cited by this paper
• Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.

  1999cited by this paper
• Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

  1998cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

  1998cited by this paper
• Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction.

  1998cited by this paper
• Imaging of the distal left anterior descending coronary artery by transthoracic color-Doppler echocardiography.

  1998cited by this paper
• Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.

  1997cited by this paper
• The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment.

  1997cited by this paper
• A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.

  1997cited by this paper
• Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction.

  1997cited by this paper
• Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

  1997cited by this paper
• TIMI frame count: a quantitative method of assessing coronary artery flow.

  1996cited by this paper
• Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements.

  1995cited by this paper
• Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease.

  1995cited by this paper
• Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses.

  1994cited by this paper
• Increased sensitivity of flow detection in the left coronary artery by transesophageal echocardiography after intravenous administration of transpulmonary stable echocontrast agent.

  1994cited by this paper
• Intracoronary Doppler guide wire versus stress single-photon emission computed tomographic thallium-201 imaging in assessment of intermediate coronary stenoses.

  1994cited by this paper
• Coronary flow velocity dynamics in normal and diseased arteries.

  1993cited by this paper
• A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

  1993cited by this paper
• Assessing the hemodynamic significance of coronary artery stenoses: analysis of translesional pressure-flow velocity relations in patients.

  1993cited by this paper
• Indoor Air Pollution: A Health Perspective

  1992cited by this paper
• Transesophageal echocardiography. New window to coronary arteries and coronary blood flow.

  1991cited by this paper
• Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation.

  1991cited by this paper
• Thrombolysis in myocardial Infarction (TIMI) trial–phase I

  1990cited by this paper
• Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

  1987cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper

• No citing papers are available for this paper.